Download Files:
Products Details
Product Description
– CVN417 is an orally active antagonist of nAChR containing the α6 subunit, modulating phasic dopaminergic neurotransmission in an impulse-dependent fashion. It inhibits Ca(2+) efflux through nAChR subunits, displaying IC50 values of 0.086 μM (α6), 2.56 μM (α3), and 0.657 μM (α4). CVN417 has shown efficacy in reducing resting tremor in rodent models, suggesting a potential to ameliorate movement disorders in conditions like Parkinson’s disease [1].
Web ID
– T78827
Storage Temperature
– -20℃
Shipping
– Blue Ice
Pathway
– Others
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
Sodium Nitroprusside
64 CAD – 139 CADPrice range: 64 CAD through 139 CAD
1000 in stock
1000 in stock
4-Hydroxy-6-methylcoumarin
46 CAD – 78 CADPrice range: 46 CAD through 78 CAD
1000 in stock